Nkarta Therapeutics Investors
Nkarta Therapeutics is a biotechnology company based in South San Francisco, California, founded in 2015 The company is focused on developing innovative cell therapies for the treatment of cancer and other serious diseases Nkarta Therapeutics has successfully raised a total of $252 million in funding to advance its research and development efforts The firm operates within a dynamic landscape of angel groups, fostering collaboration and investment in cutting-edge therapeutic solutions Its commitment to scientific excellence positions Nkarta Therapeutics as a leader in the field of immunotherapy
Industry:
FemTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2015
Investor Type:
Angel Groups
Register and Claim Ownership